Stocks
Health Care
kod
Kodiak Sciences
NASDAQ: KOD
+17.01 (+74.77%)
39.76
USD
At close at Mar 26, 20:43 UTC
Overview
Loading chart...
Key Stats
Market Cap
1.20B
Dividend Yield
0.00%
P/E Ratio
-5.53
EPS
-3.36
Revenue
-
Avg. Volume
980.57K
Recently from Cashu
No Cashu articles
Kodiak Sciences currently has no Cashu-related articles
About
What does KOD do?
Kodiak Sciences, a clinical-stage biopharmaceutical company based in Palo Alto, develops therapeutics for retinal diseases, including tarcocimab and KSI-501, using its innovative ABC Platform. The company went public on October 4, 2018, and employs 107 staff.
Join our newsletter to keep up to date with us!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.